Financials

  • Market Capitalization 305.97 M
  • Employee 641
  • Founded 2007
  • CEO N/A
  • Website www.starlingoncology.com
  • Headquarter Delaware, United States
  • FIGI BBG00S5H21H2
  • Industry N/A
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3349
VII
Viking Acquisition Corp. II
9.8500 USD0.00%+0.10%+0.31%-0.20%308.08 M USD
3351
ISOU
IsoEnergy Ltd
5.59 USD-6.83%-23.74%-32.24%-46.96%307.05 M USD
3361
QLEP
Quantum Leap Acquisition Corp
10.10 USD0.00%+0.10%+0.40%+1.51%302.79 M USD
3364
GSRV
GSR V Acquisition Corp. Class A ordinary shares
9.94 USD+0.10%+0.20%+0.30%+0.10%302.38 M USD

Frequently asked questions about Starling Oncology, Inc. Common Stock

What is the Starling Oncology, Inc. Common Stock stock price today?

The current price of Starling Oncology, Inc. Common Stock (STLN) is 3.00. Over the past 24 hours, the stock has changed by -5.66%. Follow the STLN chart for real-time price dynamics.

What is the stock ticker of Starling Oncology, Inc. Common Stock?

Starling Oncology, Inc. Common Stock trades under the ticker STLN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Starling Oncology, Inc. Common Stock stock going up?

STLN has changed by -14.77% over the last week, -55.42% over the last month, and -42.75% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Starling Oncology, Inc. Common Stock?

Starling Oncology, Inc. Common Stock currently has a market capitalization of 305.97 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Starling Oncology, Inc. Common Stock earnings last quarter?

Last quarter, Starling Oncology, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Starling Oncology, Inc. Common Stock revenue for the last quarter?

Starling Oncology, Inc. Common Stock reported quarterly revenue of 169.77 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Starling Oncology, Inc. Common Stock net income for the last quarter?

Starling Oncology, Inc. Common Stock reported net income of -15.75 M for the last quarter. The previous quarter showed -9.79 M, which means net income changed by -60.87%.

How many employees does Starling Oncology, Inc. Common Stock have?

As of the latest available data, Starling Oncology, Inc. Common Stock has 641 employees. Workforce size can provide additional context about the company's scale and operations.

What is Starling Oncology, Inc. Common Stock EBITDA?

Starling Oncology, Inc. Common Stock EBITDA is -33.59 M, and its EBITDA margin is -18.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Starling Oncology, Inc. Common Stock stock?

You can buy Starling Oncology, Inc. Common Stock (STLN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Starling Oncology, Inc. Common Stock stock?

Investing in Starling Oncology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STLN chart and related analysis on metatrader.com as part of your research.